Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Latifah Alothman"'
Autor:
Latifah Alothman, MD, Magdaline Zawadka, MD, Sumayah Aljenedil, MD, Mahesh Kajil, MD, David Bewick, MD, Daniel Gaudet, MD, PhD, Robert A. Hegele, MD, Eva Lonn, MD, MSc, Daniel Ngui, MD, Isabelle Ruel, PhD, Michelle Tsigoulis, RN, Narendra Singh, MD, Jacques Genest, MD, Milan Gupta, MD
Publikováno v:
CJC Open, Vol 1, Iss 4, Pp 190-197 (2019)
Background: The prevalence of heterozygous familial hypercholesterolemia (FH) is 1 of 250 in the general population and approximately 1 of 125 in patients with atherosclerotic cardiovascular disease (ASCVD), yet only a minority are diagnosed. The dia
Externí odkaz:
https://doaj.org/article/d21c8b93f44b4d7b97e95899bd149a9f
Autor:
Latifah Alothman, Alexandre M Bélanger, Isabelle Ruel, Liam R Brunham, Lindsay Hales, Jacques Genest, Leo E Akioyamen
Publikováno v:
Journal of Clinical Lipidology. 16:52-65
Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disease characterized by extreme elevations of low-density lipoprotein cholesterol (LDL-C) and extremely premature atherosclerotic cardiovascular disease. To date, impacts of HoFH and
Autor:
Isabelle Ruel, Zubin Lahijanian, Daniel Gaudet, Alexandre M. Bélanger, Jacques Genest, Jean Bergeron, Alexis Baass, Etienne Khoury, Latifah Alothman, Diane Brisson, Patrick Couture, Sumayah Aljenedil, Leslie Brown
Publikováno v:
Atherosclerosis. 310:54-63
Background and aims Homozygous familial hypercholesterolemia (HoFH) is an orphan disease, most often caused by bi-allelic mutations of the LDLR gene. Patients with HoFH have elevated LDL-C levels >13 mmol/L, tendinous xanthomata and severe, premature
Autor:
Zhiying Liang, Eddy Lang, Dominique Toupin, Adi J. Klil-Drori, Deepa Suryanarayan, Latifah Alothman, Meng Wang, Vicky Tagalakis, Dwip Prajapati
Publikováno v:
Medical Care. 57:e47-e52
Background Administrative health care databases are increasingly being used to study pulmonary embolism (PE), but the validity of single PE codes is variable. Using data from Quebec, Canada, we developed ASPECT (Algorithm for Suspected Pulmonary Embo
Autor:
Milan Gupta, Daniel Ngui, Sumayah Aljenedil, Eva Lonn, Robert A. Hegele, Narendra Singh, Mahesh Kajil, Jacques Genest, Magdaline Zawadka, David Bewick, Daniel Gaudet, Isabelle Ruel, Latifah Alothman, Michelle Tsigoulis
Publikováno v:
CJC Open, Vol 1, Iss 4, Pp 190-197 (2019)
CJC Open
CJC Open
Background: The prevalence of heterozygous familial hypercholesterolemia (FH) is 1 of 250 in the general population and approximately 1 of 125 in patients with atherosclerotic cardiovascular disease (ASCVD), yet only a minority are diagnosed. The dia
Publikováno v:
Current opinion in lipidology. 31(4)
Purpose of review Homozygous familial hypercholesterolemia (HoFH) is an orphan disease caused by biallelic mutations at the LDL receptor (LDLR) gene, with a prevalence estimated at 1 : 250 000 to 1 : 630 000. HoFH is characterized by extremely elevat
Autor:
Latifah Alothman, Patrick Couture, Jacques Genest, Alexandre M. Bélanger, Ambuja Banerjee, Isabelle Ruel, Jean Bergeron
Publikováno v:
The Canadian journal of cardiology. 35(10)
Homozygous familial hypercholesterolemia is caused by mutations in the low-density lipoprotein receptor gene. It is diagnosed in children or youth who present with extensive tendinous and cutaneous xanthomas and extreme elevation of low-density lipop
Autor:
Daniel Ngui, Narendra Singh, Robert A. Hegele, Sumaia Aljenedil, Mahesh Kajil, Isabelle Ruel, Milan Gupta, Magdaline Zawadka, Daniel Gaudet, David Bewick, Jacques Genest, Latifah Alothman, Eva Lonn
Publikováno v:
Journal of the American College of Cardiology. 73:90
Heterozygous familial hypercholesterolemia (FH) prevalence is 1/250, and 1/125 in ASCVD patients, yet only a minority of patients are diagnosed. Early identification and aggressive lipid-lowering reduces CV morbidity and mortality. We prospectively e